Chronic Kidney Disease

Obesity is not only comorbidity for chronic kidney disease (CKD) but may also be a risk factor for CKD. Epidemiological correlations and pathophysiological changes have been observed associating obesity with CKD. Low birth weight may be associated with both obesity and low nephron mass, leading to CKD later in life. Elevated levels of adipokines, such as leptin and adiponectin, in obesity may be factors in CKD pathogenesis and progression. Furthermore, various other factors, such as hypertension, increased cardiovascular morbidityinsulin resistancedyslipidemia, and lipotoxicity, may play significant roles in the pathogenesis of CKD in obesity. Reduction in obesity, which is a potentially modifiable risk factor, might help decrease the burden of CKD in the population. Apart from individualized options, community-based interventions have the potential to create a strong impact in this condition.

  • Increased Body Mass Index (BMI) and Risk of CKD
  • Overweight and Progression of End-Stage Renal Disease (ESRD)
  • Obesity, Metabolic Syndrome & the Risk of CKD
  • Assess & Manage Obesity in the Setting of CKD

Related Conference of Chronic Kidney Disease

June 02-03, 2025

21st Euro Obesity and Endocrinology Congress

Amsterdam, Netherlands
March 26-27, 2026

28th Global Obesity Meeting

London, UK
November 03-08 2015

Kidney Week 2015

San Diego USA
September 17-21 2016

15th Asian Pacific Congress of Nephrology APCN and ANZSN ASM

Perth Australia
March 03-06 2016

4th International Conference on PreHypertension Hypertension and CMS

Venice Italy
November 03-08 2015

American Society of Nephrology

San Diego USA
November 12-15 2015

Hands-On Abdominal Ultrasound Imaging Doppler

Dallas USA
February 27-March 1 2016

International Society for Peritoneal Dialysis

Melbourne Australia

Chronic Kidney Disease Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in